This panel will discuss long-standing tensions between privacy and innovation in contemporary medical research. Panelists will also explore new understandings of the mutually reinforcing character of privacy and innovation. For example, innovative deidentification methods might better protect privacy, and stronger legal protections for privacy may lead more patients to “buy in” and participate in research. Bringing together leading academic, industry, and government perspectives, the panel promises to spark a lively discussion on how best to realize the promise of pharmacogenomic research.
Business Meeting at Program Conclusion for Section on Biolaw.
Business Meeting at Program Conclusion for Section on Defamation and Privacy.